nsv6112688
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:copy number variation
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:8,170,804
- Description:Single allele AND multiple conditions
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 18463 SVs from 119 studies. See in: genome view
Overlapping variant regions from other studies: 18458 SVs from 119 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Outer Start | Inner Start | Inner Stop | Outer Stop |
---|---|---|---|---|---|---|---|---|---|---|---|
nsv6112688 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000003.12 | Chr3 | 120,435,341 | 120,435,341 | 128,606,144 | 128,606,144 |
nsv6112688 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000003.11 | Chr3 | 120,154,188 | 120,247,726 | 128,319,968 | 128,324,987 |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17649862 | deletion | Multiple | Multiple | Deafness-lymphedema-leukemia syndrome; GATA2 deficiency with susceptibility to MDS/AML; LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA; Lymphedema, primary, with myelodysplasia | Pathogenic | ClinVar | RCV001541924.1, VCV001183989.1 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Outer Start | Inner Start | Inner Stop | Outer Stop |
---|---|---|---|---|---|---|---|---|---|---|---|
nssv17649862 | Remapped | Perfect | NC_000003.12:g.(12 0435341_120435341) _(128606144_128606 144)del | GRCh38.p12 | First Pass | NC_000003.12 | Chr3 | 120,435,341 | 120,435,341 | 128,606,144 | 128,606,144 |
nssv17649862 | Submitted genomic | NC_000003.11:g.(12 0154188_120247726) _(128319968_128324 987)del | GRCh37 (hg19) | NC_000003.11 | Chr3 | 120,154,188 | 120,247,726 | 128,319,968 | 128,324,987 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17649862 | GRCh37: NC_000003.11:g.(120154188_120247726)_(128319968_128324987)del | deletion | unknown | Deafness-lymphedema-leukemia syndrome; GATA2 deficiency with susceptibility to MDS/AML; LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA; Lymphedema, primary, with myelodysplasia | Pathogenic | ClinVar | RCV001541924.1, VCV001183989.1 |